Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn Hlatky

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2012
Double-strand break motions shift radiation risk notions?Lynn Hlatky
Cancer Research|November 26, 2013
Beyond the cancer cell: progression-level determinants highlight the multiscale nature of carcinogenesis riskLynn Hlatky, Philip Hahnfeldt
Bulletin of Mathematical Biology|December 31, 2009
A rapid-mutation approximation for cell population dynamicsRainer K Sachs, Lynn Hlatky
Theoretical Biology & Medical Modelling|July 31, 2012
Immunoediting: evidence of the multifaceted role of the immune system in self-metastatic tumor growthHeiko Enderling, Lynn Hlatky, Philip Hahnfeldt
Journal of the National Cancer Institute|June 20, 2002
Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell usLynn Hlatky, Philip Hahnfeldt, Judah Folkman
Radiation Research|February 5, 2013
Biological effects of proton radiation: what we know and don't knowSwati Girdhani, Rainer Sachs, Lynn Hlatky
Journal of Theoretical Biology|March 8, 2003
Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basisPhilip Hahnfeldt, Judah Folkman, Lynn Hlatky
Mathematical Medicine and Biology : a Journal of the IMA|October 9, 2010
The promoting role of a tumour-secreted chemorepellent in self-metastatic tumour progressionHeiko Enderling, Lynn Hlatky, Philip Hahnfeldt
Biology Direct|April 22, 2010
Tumor morphological evolution: directed migration and gain and loss of the self-metastatic phenotypeHeiko Enderling, Lynn Hlatky, Philip Hahnfeldt
Frontiers in Oncology|April 19, 2013
Cancer Stem Cells: A Minor Cancer Subpopulation that Redefines Global Cancer FeaturesHeiko Enderling, Lynn Hlatky, Philip Hahnfeldt
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2012
Double-strand break motions shift radiation risk notions?Lynn Hlatky
Cancer Research|November 26, 2013
Beyond the cancer cell: progression-level determinants highlight the multiscale nature of carcinogenesis riskLynn Hlatky, Philip Hahnfeldt
Bulletin of Mathematical Biology|December 31, 2009
A rapid-mutation approximation for cell population dynamicsRainer K Sachs, Lynn Hlatky
Theoretical Biology & Medical Modelling|July 31, 2012
Immunoediting: evidence of the multifaceted role of the immune system in self-metastatic tumor growthHeiko Enderling, Lynn Hlatky, Philip Hahnfeldt
Journal of the National Cancer Institute|June 20, 2002
Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell usLynn Hlatky, Philip Hahnfeldt, Judah Folkman
Radiation Research|February 5, 2013
Biological effects of proton radiation: what we know and don't knowSwati Girdhani, Rainer Sachs, Lynn Hlatky
Journal of Theoretical Biology|March 8, 2003
Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basisPhilip Hahnfeldt, Judah Folkman, Lynn Hlatky
Mathematical Medicine and Biology : a Journal of the IMA|October 9, 2010
The promoting role of a tumour-secreted chemorepellent in self-metastatic tumour progressionHeiko Enderling, Lynn Hlatky, Philip Hahnfeldt
Biology Direct|April 22, 2010
Tumor morphological evolution: directed migration and gain and loss of the self-metastatic phenotypeHeiko Enderling, Lynn Hlatky, Philip Hahnfeldt
Frontiers in Oncology|April 19, 2013
Cancer Stem Cells: A Minor Cancer Subpopulation that Redefines Global Cancer FeaturesHeiko Enderling, Lynn Hlatky, Philip Hahnfeldt
Pageof 8